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Abstract
Background: Many soil-inhabiting bacteria are known to produce secondary metabolites that can suppress microorganisms
competing for the same resources. The production of antimicrobial compounds is expected to incur fitness costs for the
producing bacteria. Such costs form the basis for models on the co-existence of antibiotic-producing and non-antibiotic
producing strains. However, so far studies quantifying the costs of antibiotic production by bacteria are scarce. The current
study reports on possible costs, for antibiotic production by Pseudomonas fluorescens Pf0-1, a soil bacterium that is induced
to produce a broad-spectrum antibiotic when it is confronted with non-related bacterial competitors or supernatants of
their cultures.
Methodology and Principal Findings: We measured the possible cost of antibiotic production for Pseudomonas fluorescens
Pf0-1 by monitoring changes in growth rate with and without induction of antibiotic production by supernatant of a
bacterial competitor, namely Pedobacter sp.. Experiments were performed in liquid as well as on semi-solid media under
nutrient-limited conditions that are expected to most clearly reveal fitness costs. Our results did not reveal any significant
costs for production of antibiotics by Pseudomonas fluorescens Pf0-1. Comparison of growth rates of the antibiotic-
producing wild-type cells with those of non-antibiotic producing mutants did not reveal costs of antibiotic production
either.
Significance: Based on our findings we propose that the facultative production of antibiotics might not be selected to
mitigate metabolic costs, but instead might be advantageous because it limits the risk of competitors evolving resistance, or
even the risk of competitors feeding on the compounds produced.
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Introduction
Interference competition is an important strategy of bacterial
strains to establish and maintain themselves within microbial
communities [1]. A well-known mechanism of bacterial interfer-
ence competition is the production of antibiotics [2]. These
secondary metabolites can be targeted against more or less closely
related strains and species (e.g. bacteriocins) or against a wide
range of competitors (e.g many polyketides) [3,4,5]. Theoretical
models have demonstrated that, instead of decreasing diversity by
leaving only the most aggressive strains, microbial warfare could
actually promote diversity, with dynamic coexistence of many
strains differing in their antibiotic production and sensitivity
profiles [1,6,7,8]. These results are obtained when it is assumed
that both resistance to- and production of antibiotics come at a
fitness cost, resulting in a reduced growth rate. The ecological
trade-offs involved in investment in killing, resisting or outgrowing
competing strains is thus predicted to maintain diversity.
Because of its profound relevance to human health, the fitness
cost of bacterial resistance to antibiotics has received far more
attention than the fitness cost of bacterial antibiotic production.
Whereas it has emerged that the majority of bacterial antibiotic
resistance mechanisms comes at a fitness cost [9], as predicted by
theory [10], few studies have examined the cost of antibiotic
production. Indications for biological costs of antibiotic production
or antibiotic resistance are generally obtained by comparison of
relative fitness of wild-type strains with that of antibiotic-negative
mutant strains (e.g. [11,12]). However, mutations causing loss of
antibiotic production may cause additional changes in the
bacterial phenotype [13,14].
Previously, we have reported on competitor-induced triggering
of broad-spectrum antibiotic production in fluorescent pseudomo-
nads [15,16]. The soil isolate Pseudomonas fluorescens Pf0-1 exhibits
antibiotic activity only when it is confronted with specific
phylogenetically unrelated competitors (e.g. Pedobacter sp.) or their
supernatant indicating that it can distinguish interspecific
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structure of the antimicrobial compound has not yet been
elucidated, upregulated genes during confrontation with compet-
itors point at the synthesis of a polyketide-like compound.[16]. In
addition, we have shown that it has broad-spectrum activity,
acting against both Gram-positive and Gram-negative bacteria as
well as against fungi [16].
Competitor-dependent induction of antibiotic production allows
for another possibility to examine costs of antibiotic production
namely by comparing growth rates of wild-type bacteria with and
without induction of antibiotic production. In the current study we
used both approaches to quantify the possible fitness cost of
antibiotic production in P. fluorescens Pf0-1: 1) comparison of the
growth rate of the wild-type with and without induction of
antibiotic production and 2) comparison of the growth rate of
wild-type and non-antibiotic producing mutants under conditions
that induce antibiotic production. All experiments were performed
using nutrient-poor media, as soil-dwelling bacteria typically
experience a scarcity of easily degradable carbon resources
[17,18]. Moreover, growth limiting conditions represent a
situation in which the costs of antibiotic production should be
most pronounced as there is no surplus of energy resources [19].
Costs were measured in liquid culture as well as on semi-solid
medium in an incubation chamber, allowing quantification of
micro-colony growth.
Materials and Methods
Bacterial and fungal cultures used
The bacterial strains used in this study are Pseudomonas fluorescens
Pf0-1 (Gamma-proteobacteria) which was isolated from an
agricultural loam soil in Sherborn, Massachusetts, USA [20] and
Pedobacter sp. V48 (Sphingobacteria), which was isolated from a
coastal dune site in The Netherlands [21]. The strains were pre-
cultured from frozen glycerol stocks on 1/10 strength Tryptic Soy
Broth agar (TSBA) [15]. In addition to the parental strain, deletion
mutant DPfl01_3463-66 (with deletion of Pfl01_3463-3464: two
branched-chain alpha-keto acid dehydrogenase E1 components;
Pfl01_3465: branched-chain alpha-keto acid dehydrogenase
subunit E2 and Pfl01_3466: dihydrolipoamide dehydrogenase)
which is unable to produce the broad-spectrum antibiotic was used
as well [16]. The fungal isolate Rhizoctonia solani anastomosis group
2.2IIIB, a plant-pathogenic basidiomycete, was used as bioindi-
cator for production of broad-spectrum antimicrobial compounds
[16].
Preparation of cell-free Pedobacter supernatant
Cell-free supernatant was prepared by centrifugation (16,000 x
g for 5 min) followed by filtration (Spin-X 0.22 mm filters; Corning
Costar, Cat# 8160) of over-night cultures of Pedobacter strain V48
grown in 1/10
th strength Tryptic Soy Broth at 20
oC. An aliquot of
the cell-free supernatant was boiled for 10 minutes and was used as
a control. Boiling the cell-free supernatant for 10 minutes was
sufficient to destroy the signalling compound(s) that trigger
antibiotic production in P. fluorescens Pf0-1.
Determination of growth of Pf0-1 in nutrient-poor liquid
media
The effect of cell-free supernatant from Pedobacter sp V48 on
the growth rate of Pf0-1 was determined in a nutrient-poor liquid
medium (0.5 gL
21 KH2PO4; 0.1 gL
21 BD Bacto
TM Yeast
extract (Cat# 210934) and 0.1 gL
21(NH4)2SO4; adjusted to
pH 6.5). This medium was supplemented with 10% (v/v) boiled
(control) or unboiled Pedobacter supernatant, respectively. P.
fluorescens Pf0-1 was inoculated to an optical density (OD)
(600 nm) of 0.02 which corresponds to 2.6610
6 cells/ml
21.T h e
50 ml cultures were incubated for 24 hours at 20uCs h a k e na t
200 rpm and 1 ml samples were taken every hour for OD
measurements and viable counts. Additionally, the growth rate
of P. fluorescens Pf0-1 wild-type and mutants DPfl01_3463 (both
supplemented with 10% (v/v) boiled (control) or unboiled
Pedobacter supernatant) were measured in 96-well plates (Greiner
bio-one, Cat# 655180) using Synergy Microplate Reader. The
OD measurements were performed every 30 minutes for total
period of 8.5 hours.
Agar-incubation chambers for observation of bacterial
growth on semi-solid medium
1m lo fP. fluorescens Pf0-1 overnight culture was centrifuged for
3 min at 16,000 g. The cells were resuspended in 10 mM
phosphate buffer (pH 6.5) containing 10% non-boiled or boiled
cell-free supernatant of Pedobacter sp V48 to an optical density of
0.002 at 600 nm; so, the initial number of cells per ml was 10
times lower than in the liquid growth experiments. The lower
number was used as it allows distinguishing individual bacteria on
the agar slices (see below). An aliquot of 280 mlo fP. fluorescens
Pf0-1 bacterial suspension was equally spread on a thin layer
(2 mm) of water agar containing 5 g L
21 NaCl; 1 g L
21 KH2PO4
and 0.1g L
21 (NH4)2SO4 adjusted to pH 6.5 as previously
described [15]. Since bacterial growth was observed on this
water-agar medium no extra substrate (yeast extract) was added
[16]. Apparently, the substrates that were added with the 10%
Pedobacter supernatant and the substrates that became available
after autoclaving of agar were sufficient for growth. After
inoculation the plates were dried for about 5 minutes in a flow
cabinet and 3 slices of 1 cm
2 were cut and carefully transferred to
incubation chambers. The incubation chamber described in
Figure 1 is adapted from Reinhard and Van der Meer [22] and
Robin Tecon (unpublished data).
Microscopical counting and data analysis
Twenty randomized pictures at 400-fold magnification repre-
senting an area of 1 mm
2 were taken of each slice with an Axio
Imager M1 microscope (Carl Zeiss, Oberkochen, Germany) under
phase-contrast illumination and an AxioCam MRm camera.
Microscopic enumerations were performed every hour for a period
of 9 hours at room temperature. During this period microcolonies
remained two-dimensional, i.e. no stacking took place. Digital
images were analyzed using the AXIO VISION v4.7 Software
(Carl Zeiss Imaging Solutions GmbH, Germany) for enumeration
and area determination of bacterial colonies.
Figure 1. Incubation chamber for determination of bacterial
growth made of a glass slide with cardboard spacers on both
sides. Between the spacers 3 pre-inoculated water-agar (WA) slices of
1c m
2 are placed. A glass coverslip is slightly pressed on top of the agar
slices. The sides of the incubation chamber are sealed with parafilm.
doi:10.1371/journal.pone.0027266.g001
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inhibition
P. fluorescens Pf0-1 overnight liquid cultures exposed to 10%
boiled or unboiled supernatant of Pedobacter sp V48 (initial volume
35 ml) were acidified with trifluoroacetic acid (0.1% (v/v)), mixed
with 2 volumes of ethylacetate and shaken vigorously for 5 min. as
described by Raaijmakers et al. [23]. After overnight incubation at
220uC the unfrozen liquid (ethylacetate) fraction containing the
active compounds was carefully transferred to a new flask and
dried under constant air-flow. The dried extract was dissolved in
150 ml 50% (v/v) methanol and tested for inhibition of the
bacterial isolate Pedobacter sp V48 and the soil borne plant-
pathogenic fungus Rhizoctonia solani as described by Garbeva et al.
[16].
RNA extraction, cDNA synthesis and real-time PCR
RNA was extracted from P. fluorescens Pf0-1 grown in nutrient-
poor liquid medium that had been exposed to 10% boiled or non-
boiled supernatant of Pedobacter sp V48 as described above. Cells
for RNA extraction were collected at 4 time points (3 h, 6 h, 8 h
and 24 h) and diluted with sterile phosphate buffer to the same
optical density (600 nm) to obtain equal amounts of cells. The
RNA extraction and cDNA synthesis were performed as described
previously by Garbeva et al [16].
For real-time PCR assessment of expression of genes involved in
antibiotic production two different primer combinations were
used: (1) primer combination 3463F835 (GAT TTT TAC GCG
GTC TAC GC) and 3463R1036 (TGA TCA GGT TGC TGT
TTC AGG) amplifying 206 bp from gene Pf01_3463 encoding the
two branched-chain alpha-keto acid dehydrogenase E1 compo-
nent and (2) primer combination 3465T1F (CAG GGC CCG
ATG GTT GC) and 3465T1R (TTG CTT TTT GTG CCG
CGC TCG) amplifying 348 bp from gene Pf01_3465 encoding
branched-chain alpha-keto acid dehydrogenase subunit E2. As a
control, a 210 bp fragment of the house keeping 16S rDNA gene
was amplified using primer combination 16SPf01F (TTG GGA
GCC TTG AGC TCT TA) and 16SPf01R (AAG GCA CCA
ATC CAT CTC TG). Real-time PCR was performed using a
Corbett Research Rotor-Gene 3000 thermal cycler (Westburg,
Leusden, The Netherlands) with the following conditions: an initial
cycle of 95uC for 15 min followed by 40 cycles of: 95uC for 15 sec;
56uC for 50sec and 72uC for 50 sec. Standard curves were
established for each primer combination.
Statistical analysis
All experiments were performed in triplicate. Differences in
optical densities of liquid cultures between treatments were tested
for significance for each time interval by one-way analysis of
variance. Bacterial viable count data that were used to calculate
the maximum yield (maximum number of colony forming units
per ml) were also log-transformed prior to one-way analysis of
variance. For the analysis of microcolony development the data
were log transformed and the slopes of the regression lines were
compared in GraphPad Prism 5 (GraphPad Software, Inc., CA,
USA) using a two tailed t-test. The statistical analyses of
quantitative real-time PCR data were carried out with XLStat
2010 (Addinsoft, New York, USA) using a two-tailed t-test. Data
were considered to be statistically different at p#0.05.
Results
P. fluorescens Pf0-1 antibiotic production and growth rate
The OD measurements indicated that Pf0-1 grew only a short
period (1–2 hr) exponentially in nutrient-poor liquid media
followed by linear increase (Figure 2; Figure S1). This rapid
decline in growth rates occurred for all treatments and stationary
phase was reached after 8 hours. At none of the time intervals
(performed on 96-well plates every 30 min) were there significant
differences in OD between cultures exposed to boiled and
unboiled Pedobacter supernatant (Figure 2). The growth rate of
Pf0-1 mutant D3463, which is deficient in the production of the
broad-spectrum antimicrobial compound triggered by Pedobacter
supernatant, was also compared with that of the wild-type strain in
Figure 2. Bacterial growth (Optical Density at 600 nm) in nutrient-poor liquid medium in microplates.: Pf01wt+CFS - P. fluorescens Pf0-1
wild type with 10% cell-free supernatant from Pedobacter sp. V48; Pf01wt+BCFS - P. fluorescens Pf0-1 wild type with 10% boiled cell-free supernatant
from Pedobacter sp. V48; D3463+CFS – P. fluorescens Pf0-1 mutant D3463 with 10% cell-free supernatant from Pedobacter sp. V48 and D3463+BCFS –
P. fluorescens Pf0-1 mutant D3463 with 10% boiled cell-free supernatant from Pedobacter sp. V48. The measurements were performed every 30 min
for total period of 8.5 h. Symbols represent means of 3 replicate measurements; error bars represent standard deviations.
doi:10.1371/journal.pone.0027266.g002
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were observed (Figure 2).
Similar observations were made for the 50 ml cultures where
OD measurements were performed every hour (Figure S1). For
the latter cultures, the maximum yield (highest number of viable
cells per ml of growth medium) was calculated and again no
differences were found between the treatments (Table 1.).
The liquid cultures used for growth rate determinations were
extracted at the end of the incubation to confirm that the wild-type
Pf0-1 was induced by Pedobacter supernatant to produce antibiotics.
The presence of antibiotic activity in the extracts was tested by
determining the effect of the extracts on growth of Pedobacter sp
V48 and the soil-borne pathogenic fungus Rhizoctonia solani.
Inhibition of Rhizoctonia and Pedobacter was observed only with
the extracts from wild type Pf0-1 cultures exposed to 10% cell-free
Pedobacter supernatant (Figure S2A, B). There was no such
inhibition by the extracts obtained from Pf0-1 cultures exposed
to 10% boiled cell-free Pedobacter supernatant or from Pf0-1 mutant
D3463 cultures exposed to 10% cell-free Pedobacter supernatant.
Expression of genes involved in antimicrobial compound
production
At four time points (t=3 h, 6 h, 8 h and 24 h) during growth in
liquid medium, P. fluorescens Pf0-1 cells were collected for RNA
isolation, cDNA synthesis and quantitative RT-PCR. Primers
targeting genes Pfl01_3463 and Pfl01_3465 were used for
quantitative RT-PCR. Genes Pfl01_3463 and Pfl01_3465 encode
branch-chain alpha-keto acid dehydrogenase E1 components and
branched-chain alpha-keto acid dehydrogenase subunit E2 that
were previously demonstrated to be essential for the production of
broad-spectrum antimicrobial activity by P. fluorescens Pf0-1 [16].
Quantitative RT-PCR revealed that triggering of Pfl01_3463 and
Pfl01_3465 genes expression by Pedobacter supernatant was already
apparent after three hours, as there was a significant (3.16 and
2.57 fold respectively) increase in comparison with the expression
of these genes in cultures of Pf0-1 exposed to 10% boiled Pedobacter
supernatant (Table 2). The expression of genes Pfl01_3463 and
Pfl01_3465 was always at least two-fold higher in the Pf0-1
cultures exposed to 10% cell-free Pedobacter supernatant than in the
controls (Pf0-1 cultures exposed to 10% boiled cell-free Pedobacter
supernatant).
Effect of antibiotic production on P. fluorescens Pf0-1
growth rate on agar and microcolony morphology
Using water-agar incubation chambers we determined growth
rate and size of Pf0-1 colonies with and without induction of
antibiotic production by Pedobacter supernatant. Growth (increase
of surface areas micro-colonies) was exponential during the period
of examination (Figure 3). There was no significant difference in
growth rates between the two treatments (Figure 3A). No
significant differences in growth rates were observed between the
colonies of wild type and mutant D3463 strains either (Figure 3B).
In fact, the average colony size of Pf0-1 supplied with 10% cell-
free supernatant from Pedobacter sp V48 was slightly (but not
significantly) bigger than that of Pf0-1 supplied with boiled cell-
free supernatant. However, there was a clear difference in colony
morphology. After 7 hours of incubation, wild-type Pf0-1 exposed
to 10% Pedobacter supernatant started to form spherical colonies, a
phenomenon not observed for Pf0-1 exposed to boiled Pedobacter
supernatant or for Pf0-1 mutant D3463 exposed to unboiled
Pedobacter supernatant (Figure 4).
Discussion
Many, if not most, bacteria produce a range of secondary
metabolites that can target competing microorganisms [2,5].
Table 1. Maximum yield of P. fluorescens Pf0-1 wild-type and mutant D3463 strains in nutrient-poor liquid medium.
Treatment Maximum yield * (CFU per ml)
Pf0-1 wild-type+10% cell-free Pedobacter supernatant 7.9960.013
Pf0-1 wild-type+10% boiled cell-free Pedobacter supernatant 7.9660.022
D3463+10% cell-free Pedobacter supernatant 8.0060.021
D3463+10% boiled cell-free Pedobacter supernatant 7.9960.016
*The maximum yield calculated at time point =7.5 h is the mean of tree replicates per treatment. The variation between the replicates is indicated as 6 s.d.
One-way ANOVA did not reveal difference between the treatments p.0.05.
doi:10.1371/journal.pone.0027266.t001
Table 2. Quantitative real-time PCR comparison of gene expression in P. fluorescence Pf0-1 with triggered antibiotic production
(treatment) and non-triggered antibiotic production (control).
Time points hours Fold change treatment/ to control gene Pf01_3463 Fold change treatment/ to control gene Pf01_3465
3 3.1660.03 2.5760.11
6 2.3960.06 2.6860.03
8 2.1160.11 3.2160.14
24 2.5060.10 2.660.10
Treatment- P. fluorescence Pf0-1 with 10% cell-free supernatant of Pedobacter sp. V48 and control- - P. fluorescence Pf0-1 with 10% boiled cell-free supernatant of
Pedobacter sp. V48.
Differential expression is given as fold-changes treatment relative to the control.
The numbers are the means of tree replicates per treatment. The variation between the replicates is given as 6 s.d.
All fold changes of gene expression in the treatment were significantly different (p,0.05) from the control.
doi:10.1371/journal.pone.0027266.t002
Cost of Antibiotic Production
PLoS ONE | www.plosone.org 4 November 2011 | Volume 6 | Issue 11 | e27266Natural bacterial populations have been found to consist of a wide
variety of genotypes that differ in their ability to both suppress and
withstand conspecifics [4,24,25,26]. A trade-off between an
advantage in growth (resource or scramble competition) and an
advantage in ‘killing capacity’ or ‘resistance capacity’ (interference
competition) lies at the basis of theoretical models attempting to
explain the coexistence of strains differing in antibiotic production
and sensitivity [1,6,7,8,27,28]. The reason that not all strains
evolve to produce antibiotics thus is explained by the fact that the
production of these compounds (and their corresponding immu-
nity factors) incurs a metabolic cost. In competition in a structured
environment, antibiotic producing cells will displace sensitive (non-
antibiotic producing) cells, whereas sensitive (non-antibiotic
producing) cells have a growth rate advantage over resistant
(non-antibiotic producing) cells that in turn displace antibiotic
producing cells because they do not carry the cost of antibiotic
production [29].
Previously, it was hypothesized that the facultative- rather than
the constitutive production of antibiotics represents a cost-effective
strategy, as the antibiotic compound is only produced in situations
where it is needed [16]. Our finding that the cost of antibiotic
production in the P. fluorescens Pf0-1 system is not significant is not
in line with the cost-based assumption on basis of which theoretical
models aim to explain how microbial warfare can promote
microbial diversity. If these costs are truly insignificant then why
do not all strains produce antimicrobial compounds constitutively?
Figure 3. Bacterial growth in micro-colonies measured microscopically using Water-Agar incubation chambers. (A) white squares -wild
type P. fluorescens Pf0-1 exposed to 10% cell-free supernatant from Pedobacter sp. V48 and black squares- wild type P. fluorescens Pf0-1 exposed to
10% boiled cell-free supernatant from Pedobacter sp. V48; (B) white squares -wild type P. fluorescens Pf0-1 exposed to 10% cell-free supernatant from
Pedobacter sp. V48 and black squares- mutant D3463 exposed to 10% cell-free supernatant from Pedobacter sp. V48. Squares represent the means of
micro-colony sizes and the error bars represent the standard deviations. Statistical analysis revealed no significant differences (p.0.05) between the
growth rates (slopes) of the treatments.
doi:10.1371/journal.pone.0027266.g003
Figure 4. Morphology of bacterial micro-colonies after 7 h of incubation on Water-Agar of (A) wild type P. fluorescens Pf0-1 exposed
to 10% cell-free supernatant from Pedobacter sp. V48 (B) wild type P. fluorescens Pf0-1 exposed to 10% boiled cell-free supernatant
from Pedobacter sp. V48 and (C) - Mutant D3463 exposed to 10% cell-free supernatant from Pedobacter sp. V48.
doi:10.1371/journal.pone.0027266.g004
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work. First, facultative antibiotic production could prevent
competitors evolving resistance to the antibiotic by reducing
exposure [16]. It is evident from clinical studies that increased
exposure to antibiotics (through patient consumption) can result in
higher resistance levels in a pathogen population (e.g. [30]).
Second, it has recently emerged that many bacteria can actually
subsist on antibiotic compounds [31,32]. Although antibiotic
production could inhibit the growth of some strains competing for
resources, it could promote the growth of others. It is presently
unknown how important both mechanisms are in bacterial
populations in soil but they certainly seem worthy of future
attention.
Whilst we did not observe significant costs of antibiotic
production here, biological costs associated with antibiotic
resistance have been reported to vary from significant (e.g.
[9,33,34]), to no-cost (e.g. [14,35,36,37]) to even enhanced fitness
(e.g. [37]). This variation in costs might be explained by the fact
that the genetic systems underlying antibiotic resistance are diverse
and furthermore might not be readily comparable to those that
underlie antibiotic production (including the production of a
molecule conferring autoimmunity). Mutations conferring resis-
tance arising in sensitive cells often modify the molecule targeted
by the antibiotic in such a way that, although the cell is protected
from the antibiotic, its function is severely compromised [9]. Such
non-additive, pleiotropic fitness costs often are severe. With
antibiotic production on the other hand, it could be hypothesized
that the cells mainly bear the additive, metabolic cost of the
production of the antibiotic and the immunity molecules (which
must be small compared to the sum of all other molecules
produced by the cell) and suffer less from pleiotropic costs. In
addition, compensatory mutations that mitigate pleiotropic fitness
costs have been identified in resistant bacteria [9]. It could be that
compensatory mutations are more readily accessible for genetic
systems mediating antibiotic production than they are for
resistance mutations thus lowering the fitness cost in the former.
Although we did not observe costs for antibiotic production,
clear changes in P. fluorescens Pf0-1 colony morphology during
antibiotic production were apparent from the agar chamber
experiments. Antibiotic producing P. fluorescens Pf0-1 cells formed
spherical colonies whereas the non-producing mutant as well as
wild-type strain in the control situation did form irregular shaped
colonies. Recently it was reported that different P. fluorescens colony
morphology variants have distinct metabolic profiles [38]. It seems
plausible that the spherical colony-shape of Pf0-1 here is a
response to the produced antibiotic and not to a signal of
Pedobacter, as the mutant deficient in the production of the
antibiotics did not produce spherical colonies in the presence of
Pedobacter supernatant. Formation of such spherical colonies may
coincide with antibiotic production to obtain the highest
protection against antagonising organisms. Further studies are
needed to understand the mechanism and the biological relevance
of changes in colony morphology of P. fluorescens Pf0-1 during
antibiotic production.
Supporting Information
Figure S1 Bacterial growth (Optical Density 600 nm) in
50 ml nutrient-poor liquid cultures.: Pf01wt+CFS - wild
type P. fluorescens Pf0-1 with 10% cell-free supernatant from
Pedobacter sp. V48; Pf01wt+BCFS - wild type P. fluorescens Pf0-1
with 10% boiled cell-free supernatant from Pedobacter sp. V48;
D3463+CFS – P. fluorescens Pf0-1 mutant D3463 with 10% cell-free
supernatant from Pedobacter sp. V48. The measurements are
presented as mean 6 SD (n=3 replicates).
(TIF)
Figure S2 (A) Antagonist assay against the fungus Rhizoctonia
solani with extracts from liquid cultures (Figure S1) 1- Mutant
D3463 with 10% cell-free supernatant from Pedobacter sp. V48; 2-
wild type P. fluorescens Pf0-1 with 10% cell-free supernatant from
Pedobacter sp. V48; 3- wild type P. fluorescens Pf0-1 with 10% boiled
cell-free supernatant from Pedobacter sp. V48 and C- control 50%
methanol. (B) Effect of different extracts from liquid cultures
(Figure S1) on growth of Pedobacter sp. V48 (growing on 1/10
TSBA for 24 h) 1.Ext.wt- extract from wild type P. fluorescens Pf0-1
with 10% cell-free supernatant from Pedobacter sp. V48; 2. Ext.mut-
extract from mutant D3463 with 10% cell-free supernatant from
Pedobacter sp. V48 and 3.Con- extract from wild type P. fluorescens
Pf0-1 with 10% boiled cell-free supernatant from Pedobacter sp.
V48. 4. PdV48- Pedobacter sp. V48 without any extract. Data are
presented as mean 6 SD (n=3 replicates). * - Indicates significant
reduction of Pedobacter sp. V48 CFU as compared to other
treatments (p,0.05) as analyzed by one-way ANOVA followed
by Tukey `s HSD test.
(TIF)
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